NEW THERAPY TO TREAT RARE GASTROINTESTINAL STROMAL TUMOUR APPROVED FOR NEW ZEALAND PATIENTS
Everything Lubbock,
QINLOCK® (ripretinib) now Medsafe approved for GIST patients in NZ QINLOCK now being considered by PHARMAC for reimbursement…
QINLOCK® (ripretinib) now Medsafe approved for GIST patients in NZ QINLOCK now being considered by PHARMAC for reimbursement…
QINLOCK® (ripretinib) now Medsafe approved for GIST patients in NZ QINLOCK now being considered by PHARMAC for reimbursement…
QINLOCK® (ripretinib) now Medsafe approved for GIST patients in NZ QINLOCK now being considered by PHARMAC for reimbursement…
QINLOCK® (ripretinib) now Medsafe approved for GIST patients in NZ QINLOCK now being considered by PHARMAC for reimbursement…